Results 151 to 160 of about 7,149 (178)
Some of the next articles are maybe not open access.
Neuromyelitis optica spectrum disorder and menstruation
Revue Neurologique, 2018Gender issues and the female preponderance in neuromyelitis optica spectrum disorder (NMOSD) have been investigated before, yet the interplay between NMOSD and menstrual characteristics has remained unknown. Thus, the aim was to compare menstrual cycle patterns and their symptoms in NMOSD patients and healthy women.This cross-sectional study was ...
Shervin, Badihian +4 more
openaire +2 more sources
Treatment of neuromyelitis optica spectrum disorders
Current Opinion in Rheumatology, 2019Purpose of review This review discusses concepts for diagnosing neuromyelitis optica spectrum disorders (NMOSD), distinguishing NMOSD from other inflammatory diseases of the central nervous system, and highlights recent and forthcoming data on acute and maintenance therapy of NMOSD.
Andrew R, Romeo, Benjamin M, Segal
openaire +2 more sources
Infections in neuromyelitis optica spectrum disorder
Journal of Clinical Neuroscience, 2018Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory astrocytopathy that has both genetic and environmental causes. A growing body of evidence suggests that the presence of several infectious agents correlates with the development of NMOSD.
Zhong, X. +7 more
openaire +2 more sources
Imaging of Neuromyelitis Optica Spectrum Disorders
Seminars in Ultrasound, CT and MRI, 2020Neuromyelitis optica (NMO) is a rare and chronic disabling autoimmune astrocytopathy of the central nervous system. Current advances regarding aquaporin-4 antibody function facilitate the understanding of clinical manifestations and imaging findings beyond optic neuritis and transverse myelitis.
openaire +2 more sources
Neuromyelitis Optica Spectrum Disorders
2020Neuromyelitis optica spectrum disorders (NMOSD) are a heterogeneous group of inflammatory, demyelinating and antibody-mediated diseases of the central nervous system (CNS). The anti-aquaporin-4-IgG (AQP4-IgG) seems to be the pathogenetic agent, being present in the large majority of patients, although seronegative forms can occur.
Massimo Filippi, Maria A. Rocca
openaire +1 more source
Neuromyelitis Optica Spectrum Disorder
New England Journal of Medicine, 2022Dean M. Wingerchuk +1 more
openaire +2 more sources
Oligodendroglia in Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory autoimmune disease of the central nervous system, in which aquaporin-4 immunoglobulin G (AQP4-IgG) targets the water channel aquaporin-4 (AQP4) localized at astrocytic endfeet, thus triggering inflammatory lesions and tissue damage.Guo, Ai +3 more
openaire +3 more sources
Neuromyelitis Optica Spectrum Disorder
2019Neuromyelitis optica (NMO) is an autoimmune disease of the central nervous system, also known as Devic’s syndrome, that typically manifests with optic neuritis and transverse myelitis and, like other antibody-mediated autoimmune diseases, primarily affects women.
Samira Saadoun +2 more
openaire +1 more source